Low-dose hCG supplementation was administered at the start of ovarian stimulation, concomitantly with recombinant FSH (rFSH) in GnRH antagonist cycles, and these were compared with GnRH-a cycles that used rFSH alone. The low-dose hCG group had similar implantation and pregnancy rates but had significantly reduced rFSH requirements, allowing for an average cost savings of $600 per cycle.
|Original language||English (US)|
|Number of pages||4|
|Journal||Fertility and sterility|
|State||Published - Oct 2007|
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynecology